Quest Diagnostics (DGX)

EBITDA Margin

19.26%

TTM · Period ending:

DGX logo

DGX EBITDA Margin

Latest reported19.26%
DGX TTM EBITDA Margin (-34.02% → 19.26%)
High-resolution chart · PNG

DGX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Quest Diagnostics EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
19.2561%
19.7996%
19.7281%
19.7051%
19.6731%
19.2164%
19.1957%
18.6602%
18.746%
18.7574%
18.7203%
17.2206%
17.3482%
17.1197%
18.3952%
21.4008%
23.625%
27.9895%
29.2825%
30.8619%
31.6513%
28.3599%
25.5484%
23.5498%
19.6787%
19.4332%
20.5151%
18.5626%
18.5552%
18.5328%
18.5766%
19.1269%
18.7875%
18.8848%
18.8611%
18.9678%
19.3859%
20.5801%
19.6806%
19.3789%
23.593%
21.3117%
20.8194%
21.1107%
16.1568%
16.7375%
17.7942%
18.1716%
24.4745%
24.9969%
25.0928%
24.8449%
19.3205%
19.6804%
20.2899%
20.9445%
21.0161%
20.8312%
17.4427%
17.0441%
17.0998%
17.6033%
21.3311%
21.56%
21.828%
21.6755%
21.8798%
21.6767%
20.4177%
20.0632%
18.5835%
18.8793%
18.8835%
17.7982%
17.3001%
17.0853%
17.3756%
18.7267%
20.344%
19.9504%
20.6756%
20.6769%
20.1485%
20.5719%
20.5204%
20.2323%
20.8747%
20.4751%
20.3922%
20.3909%
20.0418%
19.5538%
18.8192%
17.9884%
17.62%
17.2325%
16.6351%
16.0901%
15.4121%
14.3152%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.